about
Skull base chordoma.Solitary plasmacytoma of bone and soft tissues.Adjuvant radiotherapy for cutaneous melanoma.Postprostatectomy radiotherapy for prostate cancer.Submandibular gland-sparing intensity-modulated radiotherapy.Radiotherapy alone or combined with chemotherapy for the treatment of squamous cell carcinoma of the base of the tongue.Primary orbital melanoma treated with orbital exenteration and postoperative radiotherapy: A case report and review of the literature.Radiotherapy for juvenile ossifying fibroma of the maxillary sinus: Case report and literature review.Mature results of a prospective study of deintensified chemoradiotherapy for low-risk human papillomavirus-associated oropharyngeal squamous cell carcinoma.Normal standard dose validityIntroductionOutcomes after surgery or definitive radiotherapy for hypopharyngeal cancerReply to Nevens et alPrognosis of subglottic carcinoma: Is it really worse?Osteoradionecrosis in osseous free flap reconstruction: Risk factors and treatmentProton therapy for skull base tumors: A review of clinical outcomes for chordomas and chondrosarcomasRadiotherapy for extranodal classic Hodgkin lymphoma of the maxillary sinus: Case report and literature reviewShoulder symptoms and quality of life impact of limited neck dissection after de-intensified chemoradiotherapy: Secondary analysis of two prospective trialsChronic opioid use in patients undergoing treatment for oropharyngeal cancerCetuximab-associated pulmonary toxicity in concurrent chemoradiation for the treatment of a squamous cell carcinoma of the head and neckRadiation treatment of soft palate squamous cell carcinomaRadiotherapy for benign head and neck paragangliomasCOVID-19 pandemic: Effects and evidence-based recommendations for otolaryngology and head and neck surgery practiceIsolated leptomeningeal progression from sinonasal carcinomas: Implications for staging workup and treatmentComparing national practice versus standard guidelines for the use of adjuvant treatment following robotic surgery for oropharyngeal squamous cell carcinomaManagement of primary skin cancer during a pandemic: Multidisciplinary recommendations
P50
Q33272255-57718687-EAB5-47FF-9E4E-21B3689CDE6CQ35580170-0835F686-E778-4EBD-B2C6-0EB46339F596Q37080022-FCE7171B-8CFF-4D9A-B045-14F252083534Q37571361-4E89D134-1DD9-4C68-A30F-567CEEEA80FCQ38034604-64E06DDF-6FEA-4E6A-9163-0BE5C796ABBAQ44715915-574BEB3F-C454-4CDC-B367-728BDA40B36DQ47545971-A5657EF8-7553-4FB6-920F-5D3808B44D43Q48198921-AD6F3E43-B631-4C7A-906B-78D7517E1818Q52724076-81B357CE-9425-438C-BCAF-EF28E4F341A7Q67928580-37780B45-3DF0-44B3-A48A-DAFEDA791332Q73548310-F08C4B5A-DB03-467C-A920-FB87C0B7F364Q84436169-78EE2FB8-4022-41C5-B775-B5A7881357EDQ88487320-6C4E40BB-B2F9-4ABF-BAAB-A77A66ACCAEDQ89273970-328828FA-C5EB-4CC2-AF0A-6235A89721B6Q90061218-E90B214A-92BB-468C-B3C5-96C81C027203Q90406039-30CCF8D7-2299-40BC-8428-7404B7333777Q90557076-F84A60CF-E5BF-4E9D-9EE7-CFF90DB3DA87Q90564767-447C6765-F608-4EE1-AFB7-2E5674223E07Q90913378-8EB4AAAF-9CB8-4509-BB58-099F80A60770Q90914261-9769760D-1B56-45EE-84FB-12CC89DC6812Q91483120-635D2478-FBAE-4422-B876-91EEC2E0B667Q91699763-83F4970A-0F17-4F99-BEDC-DC50DE6E95E6Q91750175-4621CFE6-03AC-4953-89F8-40C9F1103288Q92600216-9459CF6D-29CB-492A-A820-CD62883B7698Q96020059-858DB6D8-EF9B-48AC-AD11-069609F1EC44Q96029667-A52F8906-6544-4987-B17B-F39A344E0E8E
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
William M Mendenhall
@ast
William M Mendenhall
@en
William M Mendenhall
@es
William M Mendenhall
@nl
William M Mendenhall
@sl
type
label
William M Mendenhall
@ast
William M Mendenhall
@en
William M Mendenhall
@es
William M Mendenhall
@nl
William M Mendenhall
@sl
prefLabel
William M Mendenhall
@ast
William M Mendenhall
@en
William M Mendenhall
@es
William M Mendenhall
@nl
William M Mendenhall
@sl
P106
P21
P31
P496
0000-0002-6592-2810